Tue Sep 10 17:12:16 UTC 2024: ## Teva Faces EU Antitrust Investigation: Long-Running Case Stems From 2019 Raids
**Brussels, September 10, 2024** – Pharmaceutical giant Teva is facing an antitrust investigation by the European Union, following dawn raids conducted in 2019. The investigation, which officially commenced in 2021, stems from concerns over potential anti-competitive practices by Teva.
The investigation is the culmination of a lengthy process that began with surprise inspections at Teva’s facilities in 2019. While the specific nature of the alleged wrongdoing remains undisclosed, the EU’s investigation suggests suspicions of Teva engaging in practices that may have stifled competition within the pharmaceutical market.
Teva, headquartered in Israel, is a major player in the global pharmaceutical industry, specializing in generic drugs. The outcome of the EU’s investigation could have significant implications for the company, potentially leading to fines or other sanctions if wrongdoing is proven.
First Piper 